Matthew Nelson
Senior Director, Pharma Partnerships Natera
Seminars
Wednesday 12th November 2025
Partnering for Progress – Accelerating the Future of Oncology
2:55 pm
- Shared Vision: Natera and our pharma partners unite to advance molecular insights that transform cancer care through collaboration, innovation, and impact
- Leading with Science: As pioneers in cell-free DNA and molecular residual disease (MRD) technology, we’re helping define the standard for precision oncology and driving growth worldwide
- Delivering Value: From ctDNA and CGP to real-world data and AI, our evolving portfolio empowers biomarker-guided clinical development and accelerates breakthroughs to patients globally
